))
Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
Manage episode 289048769 series 2898408
Content provided by Arnall Golden Gregory LLP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Arnall Golden Gregory LLP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process.
9 episodes
Share
